UNSPSC 51282906: Besifloxacin hydrochloride

This classification denotes a quinolone antibiotic with the molecular formula C19H21CLFN3O3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7506A6J57T. The term besifloxacin hydrochloride is a United States Adopted Name designation. Most nations schedule besifloxacin hydrochloride under HS 29334900 and SITC 51575. As of Q4 2014, BESIFLOXACIN HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Besifloxacin hydrochloride bears US NLM identifiers UMLS ID C2710017 and NCI Concept Code C76228.

SMILES: C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl.

UNSPSC 51282906 Besifloxacin hydrochloride, a Commodity code, shows minimal recent activity directly tied to the antibiotic pharmaceutical itself; instead, state and local opportunities tagged under this code reflect broader pharmaceutical procurement including naloxone, drug deactivation systems, medical and first aid supplies, and generic multi-source pharmaceuticals distributed through established wholesaler networks. The scope of work involves procurement of pharmaceutical products and medical supplies for public health agencies, fire departments, and state health programs, typically requiring vendors to meet FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, and specific insurance coverages (commercial general liability, workers' compensation, professional liability). Issuing bodies span state health commissions, county health departments, municipal fire rescue divisions, and multistate cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and Texas Health and Human Services Commission appear as repeat buyers conducting formal pharmaceutical solicitations.

Recent activity concentrates in Texas, Florida, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response date and quarterly deliveries required to Sanford, Florida. The City of Tampa released IFB 26P00145 on March 25, 2026, for medical and first aid supplies including respiratory equipment, cardiac electrodes, and consumables for the Tampa Fire Department Rescue Division, with a March 13, 2026 deadline and an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Department of Administration's MMCAP issued RFP S1070000015802 on January 20, 2026, establishing contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with proposals due March 26, 2026, and contract effectiveness set for July 1, 2026. Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program with an April 3, 2026 response deadline, functioning as preliminary market intelligence to inform future formal procurement.